- Home
- GYRE vs CMTG Comparison
GYRE vs CMTG Comparison
Compare GYRE & CMTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GYRE
- CMTG
- Stock Information
- Founded
- GYRE 2002
- CMTG 2015
- Country
- GYRE United States
- CMTG United States
- Employees
- GYRE N/A
- CMTG N/A
- Industry
- GYRE Biotechnology: Pharmaceutical Preparations
- CMTG Real Estate Investment Trusts
- Sector
- GYRE Health Care
- CMTG Real Estate
- Exchange
- GYRE Nasdaq
- CMTG Nasdaq
- Market Cap
- GYRE 990.4M
- CMTG 881.0M
- IPO Year
- GYRE N/A
- CMTG 2021
- Fundamental
- Price
- GYRE $7.72
- CMTG $3.74
- Analyst Decision
- GYRE
- CMTG Hold
- Analyst Count
- GYRE 0
- CMTG 7
- Target Price
- GYRE N/A
- CMTG $4.31
- AVG Volume (30 Days)
- GYRE 221.1K
- CMTG 2.1M
- Earning Date
- GYRE 03-17-2025
- CMTG 05-05-2025
- Dividend Yield
- GYRE N/A
- CMTG 9.27%
- EPS Growth
- GYRE N/A
- CMTG N/A
- EPS
- GYRE 0.05
- CMTG N/A
- Revenue
- GYRE $105,757,000.00
- CMTG $9,029,000.00
- Revenue This Year
- GYRE $51.85
- CMTG $1,879.07
- Revenue Next Year
- GYRE $29.83
- CMTG $2.19
- P/E Ratio
- GYRE $155.02
- CMTG N/A
- Revenue Growth
- GYRE N/A
- CMTG N/A
- 52 Week Low
- GYRE $7.00
- CMTG $2.13
- 52 Week High
- GYRE $19.00
- CMTG $9.81
- Technical
- Relative Strength Index (RSI)
- GYRE 33.88
- CMTG 54.90
- Support Level
- GYRE $8.65
- CMTG $3.66
- Resistance Level
- GYRE $9.50
- CMTG $3.97
- Average True Range (ATR)
- GYRE 1.02
- CMTG 0.27
- MACD
- GYRE -0.24
- CMTG 0.00
- Stochastic Oscillator
- GYRE 12.81
- CMTG 48.17
About GYRE Gyre Therapeutics Inc.
Gyre Therapeutics Inc is a biopharmaceutical company headquartered in San Diego, CA, that is primarily focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis), formerly known as Nonalcoholic Steatohepatitis (NASH)) in the United States. In the United States, Hydronidone is currently being evaluated for the treatment of liver fibrosis across a broad spectrum of chronic liver diseases under an active Investigational New Drug (IND) application. Gyre is also advancing a diverse pipeline in China through a controlling interest in the Beijing Continent, including pirfenidone, F573, F528, and F230.
About CMTG Claros Mortgage Trust Inc.
Claros Mortgage Trust Inc is a real estate investment trust. The company is focused mainly on originating senior and subordinate loans on transitional commercial real estate assets located in markets across the U.S.